GO:0035925 mRNA 3'-UTR AU-rich region binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0035925 describes the molecular function of binding to AU-rich elements (AREs) in the 3' untranslated region of mRNAs, with a consensus sequence of UUAUUUAUU.
• ARE-binding proteins control mRNA stability and translation, thereby regulating gene expression post-transcriptionally.
• Key ARE-binding proteins include ZFP36 (TTP), which promotes mRNA decay, and others that stabilize transcripts.
• Dysregulation of ARE-mediated decay is linked to inflammatory diseases, cancer, and metabolic disorders.
• Studying this function requires methods such as RNA immunoprecipitation, reporter assays, and CRISPR-based editing.
• EDITGENE provides CRISPR services to model ARE-binding protein functions in disease research.
Description
The molecular function defined by GO:0035925, mRNA 3'-UTR AU-rich region binding, is a critical post-transcriptional regulatory mechanism. It involves the specific recognition of adenine- and uridine-rich sequences in the 3' untranslated region of mRNAs by RNA-binding proteins. These interactions govern the fate of mRNAs, influencing their stability, localization, and translation efficiency. This function is essential for rapid cellular responses to stimuli, such as immune activation and stress. Researchers study this term to understand how gene expression is fine-tuned and how its disruption contributes to diseases like cancer and inflammation. The binding of proteins to AU-rich elements (AREs) is a paradigm for post-transcriptional control, with the consensus sequence UUAUUUAUU being a key determinant.
mRNA 3'-UTR AU-rich region binding At A Glance
| GO ID | GO:0035925 |
|---|---|
| GO term | mRNA 3'-UTR AU-rich region binding |
| Ontology | molecular_function |
| Synonym | ARE binding; AU-rich element binding; adenylate/uridylate-rich element binding |
| Major function | Binding to AU-rich elements in mRNA 3' UTR to regulate mRNA stability and translation |
| Consensus sequence | UUAUUUAUU |
| Location | 3' untranslated region of mRNA or pre-mRNA intron |
| Key proteins | ZFP36 (TTP), KHSRP, ELAVL1, etc. |
What Is GO:0035925?
GO:0035925 is a molecular function term describing the binding to a region containing frequent adenine and uridine bases within the 3' untranslated region of a mRNA molecule or in pre-mRNA intron. The ARE-binding element consensus is UUAUUUAUU. ARE-binding proteins control the stability and/or translation of mRNAs.
Why Is mRNA 3'-UTR AU-rich region binding Important in Cell Biology?
Understanding mRNA 3'-UTR AU-rich region binding is fundamental to deciphering post-transcriptional gene regulation. This function allows cells to rapidly modulate gene expression without new transcription, which is vital for processes like immune response, cell growth, and differentiation. Dysregulation of ARE-binding proteins is implicated in a wide range of diseases, including cancer, chronic inflammation, and metabolic disorders. Therefore, targeting these interactions offers potential therapeutic avenues, and studying them requires precise molecular tools.
• Controls mRNA half-life and translation efficiency of many cytokines, growth factors, and oncogenes.
• Enables rapid response to environmental cues such as infection or stress.
• Dysregulation leads to inflammatory diseases like rheumatoid arthritis and cancer.
• ARE-binding proteins are potential drug targets for anti-inflammatory and anti-cancer therapies.
• Provides a model for studying RNA-protein interactions and phase separation.
• Essential for understanding post-transcriptional gene regulation in development.
• Involved in metabolic regulation, including glycolysis in T cells.
• Plays a role in lipid metabolism via LDL receptor mRNA stabilization.
• Can be studied using CRISPR to create knockout or knock-in models.
• Offers insights into mRNA vaccine design and stability.
What Happens During mRNA 3'-UTR AU-rich region binding?
Recognition of AU-rich elements
In simple terms: Proteins scan mRNA for specific AU-rich sequences.
ARE-binding proteins recognize the UUAUUUAUU consensus sequence in the 3' UTR of target mRNAs. This binding is mediated by RNA-binding domains such as CCCH zinc fingers or RNA recognition motifs. The interaction is sequence-specific and often involves multiple proteins forming complexes.
Regulation of mRNA stability
In simple terms: Binding can either protect or destroy the mRNA.
Upon binding, ARE-binding proteins recruit exonucleases or decapping enzymes to promote mRNA degradation, or they can stabilize the transcript by preventing decay. For example, ZFP36 (TTP) promotes deadenylation and decay of mRNAs containing AREs. Conversely, some proteins like ELAVL1 stabilize mRNAs.
Translational control
In simple terms: Binding can also affect how efficiently mRNA is translated into protein.
ARE-binding proteins can inhibit translation initiation or elongation by interacting with the ribosome or translation factors. This provides an additional layer of control beyond mRNA stability.
Integration with cellular signaling
In simple terms: External signals can change how these proteins bind.
Signaling pathways such as MAPK and mTOR modulate the activity of ARE-binding proteins through phosphorylation, altering their affinity for target mRNAs. This allows dynamic responses to environmental changes.
Key Genes Involved in GO:0035925 mRNA 3'-UTR AU-rich region binding
The following genes encode proteins that bind to AU-rich elements and mediate post-transcriptional regulation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ZFP36 | Promotes mRNA decay by binding AREs | Inflammation, cancer, autoimmune diseases |
| ZFP36L1 | mRNA destabilization | T cell development, cancer |
| ZFP36L2 | mRNA decay | Embryonic development, hematopoiesis |
| ELAVL1 | mRNA stabilization | Cancer, inflammation |
| KHSRP | mRNA decay and splicing | Cancer, neuronal development |
| HNRNPD | mRNA stability and translation | Cancer, senescence |
| CELF1 | mRNA stability and translation | Myotonic dystrophy, cancer |
| CELF2 | mRNA processing | T cell function |
| AUF1 | mRNA decay | Inflammation, cancer |
| TIA1 | Stress granule formation, splicing | Neurodegeneration |
| TIAL1 | mRNA stability | Apoptosis, stress response |
| PABPC1 | Poly(A) binding, stability | Translation, mRNA decay |
| NCL | mRNA stabilization | Cancer |
| YBX1 | mRNA packaging, stability | Cancer |
| IGF2BP1 | mRNA stability and translation | Cancer |
| IGF2BP2 | mRNA stability | Metabolism, cancer |
| IGF2BP3 | mRNA stability | Cancer |
| STAU1 | mRNA decay | Neurodevelopment |
How Is mRNA 3'-UTR AU-rich region binding Regulated?
The activity of ARE-binding proteins is regulated by various signaling pathways. For instance, the p38 MAPK pathway phosphorylates ZFP36, affecting its stability and localization. mTOR signaling influences translation and can impact ARE-mediated decay. Additionally, microRNAs and other RNA-binding proteins can compete or cooperate with ARE-binding proteins, adding complexity to the regulation.
mRNA 3'-UTR AU-rich region binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ZFP36 | Inflammatory diseases, arthritis | Knockout mouse, macrophage cell lines |
| ELAVL1 | Cancer (e.g., breast, colon) | Xenograft models, CRISPR knockout |
| CELF1 | Myotonic dystrophy | Patient-derived cells, knock-in mice |
| HNRNPD | Cancer, aging | Knockout cell lines |
| TIA1 | Neurodegeneration (ALS, FTD) | Knock-in mice, iPSC-derived neurons |
Inflammation and autoimmune diseases
Dysregulated ARE-binding proteins lead to excessive production of pro-inflammatory cytokines. ZFP36 knockout mice develop severe inflammatory syndromes, highlighting its role in restraining inflammation. In rheumatoid arthritis, reduced ZFP36 activity correlates with increased TNF-alpha production.
Cancer
Many oncogenes and tumor suppressors contain AREs in their 3' UTRs. Overexpression of ELAVL1 stabilizes oncogenic mRNAs, promoting tumor growth. Conversely, loss of ZFP36 leads to stabilization of proto-oncogenes, contributing to cancer progression.
Metabolic disorders
ARE-mediated regulation affects lipid and glucose metabolism. For example, chenodeoxycholic acid stabilizes LDL receptor mRNA via an ARE-binding protein, impacting cholesterol homeostasis. In T cells, aerobic glycolysis is post-transcriptionally controlled by ARE-binding proteins.
From mRNA 3'-UTR AU-rich region binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does ZFP36 binding to a specific ARE regulate mRNA stability? | Point mutation of the ARE sequence in the 3' UTR using CRISPR |
| What is the effect of ZFP36 knockout on inflammatory gene expression? | ZFP36 knockout cell line or mouse |
| Can we tag endogenous ZFP36 to study its interactions? | Knock-in of a fluorescent or affinity tag using CRISPR |
| Does overexpression of ELAVL1 stabilize oncogenic mRNAs? | Overexpression cell line via lentiviral transduction |
| Which mRNAs are bound by a specific ARE-binding protein? | CRISPR knockout followed by RNA immunoprecipitation |
| How do disease-associated mutations in ARE-binding proteins affect function? | Point mutation knock-in using CRISPR |
How to Study the mRNA 3'-UTR AU-rich region binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA immunoprecipitation (RIP) | Binding of proteins to specific mRNAs | Identify target transcripts of ARE-binding proteins |
| Luciferase reporter assay | Effect of AREs on mRNA stability/translation | Test regulatory elements and protein function |
| CRISPR knockout | Loss-of-function phenotype | Determine gene necessity in ARE-mediated regulation |
| RNA-seq | Global mRNA abundance changes | Identify downstream effects of ARE-binding protein perturbation |
| Ribo-seq | Translation efficiency | Distinguish translational from stability effects |
| CLIP-seq | Protein-RNA binding sites at nucleotide resolution | Map exact binding sites of ARE-binding proteins |
| Western blot | Protein expression levels | Validate changes in target protein abundance |
| Immunofluorescence | Subcellular localization | Assess co-localization with stress granules or P-bodies |
RNA immunoprecipitation (RIP)
RIP uses antibodies against ARE-binding proteins to pull down associated mRNAs, followed by RT-qPCR or sequencing to identify bound transcripts. This method reveals the repertoire of mRNAs regulated by a specific protein.
Reporter assays
Luciferase reporters containing the 3' UTR of interest with wild-type or mutated AREs are used to measure the impact of ARE-binding proteins on mRNA stability or translation. This provides a quantitative readout of regulatory effects.
CRISPR-based editing
CRISPR can be used to knockout ARE-binding protein genes, mutate specific ARE sequences, or knock-in tags. These models help establish causality between binding events and phenotypic outcomes.
Transcriptome-wide analysis
RNA-seq after knockdown or knockout of an ARE-binding protein identifies global changes in mRNA abundance, revealing target networks. Combining with ribosome profiling (Ribo-seq) distinguishes effects on stability versus translation.
How CRISPR Can Be Used to Study GO:0035925 mRNA 3'-UTR AU-rich region binding
Knockout
CRISPR knockout of ARE-binding protein genes (e.g., ZFP36) in cell lines or mice allows researchers to study loss-of-function phenotypes, such as increased mRNA stability of target genes and enhanced inflammatory responses.
Point Mutation
Introducing point mutations in the ARE consensus sequence within a target mRNA's 3' UTR using CRISPR base editing or homology-directed repair can abolish protein binding, revealing the functional significance of specific AREs.
Knock-in
Knock-in of epitope tags (e.g., FLAG, HA) or fluorescent proteins into endogenous ARE-binding protein loci enables tracking and immunoprecipitation of the protein under native regulation.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of ARE-binding proteins can be used to study gain-of-function effects, such as stabilization of oncogenic mRNAs or suppression of inflammation.
How EDITGENE Supports mRNA 3'-UTR AU-rich region binding Research
Researchers studying mRNA 3'-UTR AU-rich region binding-related genes often need to determine whether a candidate gene is causally involved in a specific biological process or disease. EDITGENE provides comprehensive CRISPR-based services to create precisely engineered cell models, enabling rigorous functional studies.
Contact EDITGENE today to design your custom CRISPR model for mRNA 3'-UTR AU-rich region binding research.
Frequently Asked Questions About mRNA 3'-UTR AU-rich region binding
What is mRNA 3'-UTR AU-rich region binding?
It is a molecular function where proteins bind to AU-rich elements in the 3' untranslated region of mRNAs, regulating their stability and translation.
What genes are involved in mRNA 3'-UTR AU-rich region binding?
Key genes include ZFP36, ELAVL1, KHSRP, HNRNPD, and CELF1, among others.
What is the consensus sequence for AU-rich elements?
The consensus sequence is UUAUUUAUU, as defined in GO:0035925.
How does AU-rich element binding affect mRNA?
It can either stabilize or destabilize the mRNA and can also inhibit or enhance translation.
What diseases are associated with defects in AU-rich element binding?
Inflammatory diseases, cancer, and metabolic disorders are linked to dysregulation of ARE-binding proteins.
What methods are used to study AU-rich element binding?
Common methods include RNA immunoprecipitation, reporter assays, CRISPR knockout, and RNA-seq.
Can CRISPR be used to study AU-rich element binding?
Yes, CRISPR can create knockouts, point mutations, knock-ins, and overexpression models to study ARE-binding proteins and elements.
What is the role of ZFP36 in AU-rich element binding?
ZFP36 (TTP) binds to AREs and promotes mRNA decay, acting as a key anti-inflammatory regulator.
How is AU-rich element binding regulated?
It is regulated by signaling pathways such as MAPK and mTOR, which modify ARE-binding protein activity.
Why is AU-rich element binding important for drug discovery?
It offers targets for modulating mRNA stability in diseases like cancer and inflammation, potentially leading to new therapies.
Conclusion
GO:0035925 mRNA 3'-UTR AU-rich region binding is a fundamental post-transcriptional regulatory mechanism with broad implications for cell biology and disease. Understanding its components and regulation provides insights into gene expression control and offers opportunities for therapeutic intervention. EDITGENE's CRISPR services empower researchers to dissect this pathway with precision and scale.
References
- 1. Ma W et al.. 2018. A Membraneless Organelle Associated with the Endoplasmic Reticulum Enables 3'UTR-Mediated Protein-Protein Interactions.. Cell 175(6):1492-1506.e19 PMID: 30449617
- 2. Chang CH et al.. 2013. Posttranscriptional control of T cell effector function by aerobic glycolysis.. Cell 153(6):1239-51 PMID: 23746840
- 3. Dolicka D et al.. 2020. mRNA Post-Transcriptional Regulation by AU-Rich Element-Binding Proteins in Liver Inflammation and Cancer.. Int J Mol Sci 21(18) PMID: 32932781
- 4. Yashiro T et al.. 2011. Chenodeoxycholic acid stabilization of LDL receptor mRNA depends on 3'-untranslated region and AU-rich element-binding protein.. Biochem Biophys Res Commun 409(2):155-9 PMID: 21473855
- 6. Makita S et al.. 2021. Post-Transcriptional Regulation of Immune Responses and Inflammatory Diseases by RNA-Binding ZFP36 Family Proteins.. Front Immunol 12:711633 PMID: 34276705
- 7. Struhl K. 2024. How is polyadenylation restricted to 3'-untranslated regions?. Yeast 41(4):186-191 PMID: 38041485
